Operating Company Healthcare

Real Chemistry

San Francisco, California, United States

Formerly known as W2O, W2O Group, W2O Group (W2O)

Healthcare marketing and technology company providing analytics-driven, technology-enabled marketing, communications, and market access/real-world evidence capabilities for life sciences and healthcare clients.

Focus Areas
Patient Data & Analytics, Real-World Evidence, Patient Engagement / Segmentation

Tracked deals

3

3 tracked deals across 2020-2021.

Recent pace

0

0 tracked deals announced in the last 12 months.

Deal mix

Addon

3 addon

Real Chemistry Acquisition Volume by Year

Last 2 years

Acquisition volume by year Annual acquisition counts for the last 2 years for Real Chemistry. 2 2020 1 2021

Supporting Data

Recent Transactions

  • Buyer
    W2O, New Mountain Capital
    Target
    Swoop, IPM.ai
    Seller
    U.S. Venture Partners, Archer Venture Partners, Other investors (unnamed)
    Industry
    Data & Analytics
    Location
    United States
    Type
    Addon

    W2O, a portfolio company of New Mountain Capital, has acquired healthcare-focused data and AI companies Swoop and IPM.ai. The deal folds Swoop and IPM.ai into W2O's new health technology business to expand its AI-driven patient analytics, real-world evidence, and audience-targeting capabilities; leadership from the acquired companies will remain with W2O.

  • September 24, 2020
    Buyer
    W2O
    Target
    Elysia Group
    Type
    Addon

    W2O has acquired Elysia Group, a health economics and outcomes research (HEOR) consultancy that operates in the United States and Asia Pacific. The founders of Elysia joined W2O to lead its Health Economics and Real-World Evidence practice and the capability will integrate with W2O's recently acquired Discern Health to expand market access and evidence-generation services.

  • Buyer
    W2O Group, New Mountain Capital
    Target
    Discern Health
    Type
    Addon

    W2O Group has acquired Discern Health, a health economics and outcomes research (HEOR) consulting firm with offices in Baltimore and Washington, D.C. The deal—an add-on to W2O (a portfolio company of New Mountain Capital)—expands W2O's value‑based care, market access, HEOR and health policy capabilities.

Related Acquisition Pages

Selling a company? Get in front of buyers like Real Chemistry

Turn tracked acquisition activity into an outreach-ready buyer list.